National Pharmacy Health & Leadership Alliance Verify a MemberMember Login
NPHLANational Pharmacy Health & Leadership Alliance
Apply for Membership

03Aesthetics & LongevityWhat Changed TodayUpdated

What changed today in Aesthetics & Longevity: 1 final rule, 1 new study, 1 trial update

Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.

By NPHLA IntelligencePublished Last updated Automated from official records

The signal

NPHLA tracked 3 new official records on this desk today: 1 final rule, 1 new study, 1 trial update.

Why this matters

New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.

What changed

  1. Final rule published: Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient….[1]
  2. New research in Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]: “Innovation With Dermal Fillers: HA-CaHA”.[2]
  3. New trial registered: toxin (Can TrenibotulinumtoxinE Reverse OnabotulinumtoxinA Effect in Treating Lateral Canthal Lines?)[3]
  4. Also reported by Dermatology Times: “Where Patients With Alopecia Areata Fit on the Path to Systemic Treatment”.[4]

Who this affects

  • Med spas
  • Medical directors
  • Prescribers
  • Practice owners & operators
  • Pharmacies

What to watch next

“Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center…” takes effect Dec 31, 2026[1]

NPHLA takeaway

These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.

Source file

  1. [1]
  2. [2]
    Innovation With Dermal Fillers: HA-CaHA

    Peer reviewedDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

  3. [3]
  4. [4]
    Where Patients With Alopecia Areata Fit on the Path to Systemic Treatment

    News reportingDermatology TimesIndustry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.

Update timeline

  1. First published.
  2. Added 1 new official record.
  3. Added 1 new official record.